Skip to main content
NE

Neurodon

Crown Point, United States
Last funding
$2.9M
GrantOct 2023

Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.

Backed byBreakthrough T1DNational Institutes of Health

About Neurodon

How much funding has Neurodon raised?

Neurodon has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in October 2023.

Who are Neurodon's investors?

Neurodon's investors include Breakthrough T1D, National Institutes of Health.

Where is Neurodon headquartered?

Neurodon is headquartered in Crown Point, United States.

What does Neurodon do?

Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.

What stage is Neurodon at?

Neurodon is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Neurodon — Funding & Investors." VCBacked, October 3, 2023, https://www.vcbacked.co/company/neurodon. Accessed November 21, 2026.
APA
VCBacked. (2023). Neurodon — Funding & Investors. Retrieved November 21, 2026, from https://www.vcbacked.co/company/neurodon
Wikipedia (cite web)
{{cite web |title=Neurodon — Funding & Investors |url=https://www.vcbacked.co/company/neurodon |website=VCBacked |access-date=November 21, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Neurodon? Request a listing update

Founder contacts
m***@neurodon.net
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →